Listen Now

Topics Covered

  • Overview of Non-Hodgkin Lymphoma (NHL)
  • Signs & Symptoms, in the Context of COVID-19 & Its Variants
  • NHL Staging & Subtypes
  • Indolent & Aggressive NHL
  • Relapsed & Refractory NHL
  • Novel Treatment Approaches
  • The Role of Clinical Trials
  • How Research Adds to Your Treatment Options
  • Your Comfort Level with Adherence
  • Managing Treatment Side Effects, Symptoms & Discomfort, in the Context of COVID-19
  • Communicating with Your Health Care Team about Quality-of-Life Concerns
  • Follow-Up Care Appointments
  • The Increasing Role of Telehealth/ Telemedicine Appointments,
  • Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology, List of Questions & Discussion of OpenNotes
  • Questions for Our Panel of Experts

Our Panel of Experts

Andrew M. Evens, DO, MSc, FACP

Associate Vice Chancellor, Clinical Innovation & Data Analytics, Rutgers Biomedical and Health Sciences, Associate Director (Clinical Services), Rutgers Cancer Institute of New Jersey, System Director of Medical Oncology, and Oncology Lead for RWJBarnabas-Rutgers Medical Group, RWJBarnabas Health, Professor of Medicine, Rutgers Robert Wood Johnson Medical School

Thomas M. Habermann, MD

Professor of Medicine, Mayo Clinic College of Medicine

Christina Poh, MD

Physician, Seattle Cancer Care Alliance, Assistant Professor, Division of Medical Oncology, University of Washington, School of Medicine

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Senior Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop(pdf)

Workshop Date

This workshop was originally recorded on May 12, 2022.

Search by:

Diagnosis

Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.